Shandong Weigao Orthopaedic Device Co., Ltd (SHA: 688161)
China
· Delayed Price · Currency is CNY 24.09
-0.30 (-1.23%)
Jan 15, 2025, 9:30 AM CST
Shandong Weigao Orthopaedic Device Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 154.6 | 112.32 | 600.7 | 690.32 | 558.4 | 441.67 | Upgrade
|
| Depreciation & Amortization | 56.37 | 56.37 | 56.91 | 51.48 | 41.65 | 35.79 | Upgrade
|
| Other Amortization | 49.53 | 49.53 | 42.02 | 42.34 | 42.01 | 44.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | -0.02 | -0.27 | -0.03 | 0.42 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.2 | 0.2 | 0.04 | 3.81 | 18.72 | 10.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | -27.69 | -27.69 | -27.57 | -22.78 | -0 | -0.97 | Upgrade
|
| Provision & Write-off of Bad Debts | -5.29 | -5.29 | 15.02 | 10.13 | 4.1 | 7.61 | Upgrade
|
| Other Operating Activities | 75.43 | 21.08 | 1.62 | 1.35 | 3.71 | -0.09 | Upgrade
|
| Change in Accounts Receivable | 227.83 | 227.83 | -105.88 | -102.56 | -14.18 | 14.74 | Upgrade
|
| Change in Inventory | -160.54 | -160.54 | -143.72 | -49.72 | -182.1 | -130.64 | Upgrade
|
| Change in Accounts Payable | -137.02 | -137.02 | 69.28 | 169.3 | 187.38 | 129.1 | Upgrade
|
| Operating Cash Flow | 216.07 | 119.44 | 508.56 | 788.25 | 644.12 | 534.15 | Upgrade
|
| Operating Cash Flow Growth | -8.66% | -76.51% | -35.48% | 22.38% | 20.59% | 64.63% | Upgrade
|
| Capital Expenditures | -26.12 | -42.98 | -115.76 | -112.41 | -49.59 | -28.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.62 | 2.08 | 1.41 | 0.21 | 0.37 | 0.77 | Upgrade
|
| Cash Acquisitions | - | -43.22 | - | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | 0 | - | Upgrade
|
| Investment in Securities | 38 | -20 | -90 | -1,090 | -4.41 | -13.62 | Upgrade
|
| Other Investing Activities | 11.85 | 10.46 | 48.71 | 12.06 | - | 0.97 | Upgrade
|
| Investing Cash Flow | 38.44 | -81.57 | -129.46 | -1,188 | -46.35 | -40.48 | Upgrade
|
| Long-Term Debt Repaid | - | -4.83 | -4.85 | -4.45 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 3.72 | -4.83 | -4.85 | -4.45 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,405 | - | 500 | Upgrade
|
| Repurchase of Common Stock | -45.01 | -45.01 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -48 | -163.99 | -211.44 | - | -800 | -0.03 | Upgrade
|
| Other Financing Activities | -20.52 | -710.54 | -12.39 | -46.58 | -7.77 | 12.95 | Upgrade
|
| Financing Cash Flow | -109.82 | -924.36 | -228.68 | 1,354 | -807.77 | 512.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.26 | 0.18 | -0.55 | -0.09 | -0.4 | -0.44 | Upgrade
|
| Net Cash Flow | 144.44 | -886.31 | 149.88 | 953.8 | -210.39 | 1,006 | Upgrade
|
| Free Cash Flow | 189.96 | 76.46 | 392.8 | 675.84 | 594.54 | 505.21 | Upgrade
|
| Free Cash Flow Growth | -4.06% | -80.53% | -41.88% | 13.67% | 17.68% | 86.52% | Upgrade
|
| Free Cash Flow Margin | 14.79% | 5.96% | 19.09% | 31.38% | 32.60% | 32.10% | Upgrade
|
| Free Cash Flow Per Share | 0.47 | 0.19 | 0.98 | 1.78 | 1.66 | 1.52 | Upgrade
|
| Cash Interest Paid | 0.21 | 0.21 | 0.54 | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | -267.61 | -346.92 | 368.51 | 290.1 | 291.06 | Upgrade
|
| Levered Free Cash Flow | 268.69 | 452.76 | 230.39 | 488.41 | -347.67 | 1,225 | Upgrade
|
| Unlevered Free Cash Flow | 269.23 | 453.36 | 230.78 | 488.79 | -347.67 | 1,225 | Upgrade
|
| Change in Net Working Capital | -126.1 | -350.39 | 142.8 | -26.95 | 793.23 | -866.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.